EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.6.1.45 | Abscess |
29073888 |
Effective and rapid treatment of wound botulism, a case report. |
causal interaction diagnostic usage unassigned |
2 4 0 |
3.6.1.45 | Adenocarcinoma |
21788400 |
Tumor-specific targeting of pancreatic cancer with Shigatoxin B-subunit. |
causal interaction unassigned |
3 0 |
3.6.1.45 | Alveolar Bone Loss |
17949339 |
Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit. |
ongoing research therapeutic application unassigned |
4 3 0 |
3.6.1.45 | Alzheimer Disease |
24281246 |
Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers. |
ongoing research unassigned |
3 0 |
3.6.1.45 | Alzheimer Disease |
25469702 |
Oral administration of a fusion protein between the cholera toxin B subunit and the 42-amino acid isoform of amyloid-? peptide produced in silkworm pupae protects against Alzheimer's disease in mice. |
unassigned |
0 |
3.6.1.45 | Amyotrophic Lateral Sclerosis |
16807056 |
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. |
unassigned |
0 |
3.6.1.45 | Anaphylaxis |
25700434 |
Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells. |
unassigned |
0 |
3.6.1.45 | Anthrax |
12805360 |
The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol. |
ongoing research unassigned |
4 0 |
3.6.1.45 | Anthrax |
17942931 |
Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth. |
therapeutic application unassigned |
1 0 |
3.6.1.45 | Anthrax |
24434511 |
Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins. |
unassigned |
0 |